OQROGet OQRO Pro
Insider trade

Thermo Fisher Scientific (TMO)President & COO sold ~$185K

Gianluca Pettiti, President & COO at Thermo Fisher Scientific, sold ~$185K of Thermo Fisher Scientific shares.

~$185K
Approx. value · 400 sh @ $462.66
25K
Holds after · shares reported
Traded
Apr 27, 2026
Filed
Apr 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 3, 2026Insider · 1 personInsiders: 12 sales (~$2.5M)
  2. Mar 4, 2026Insider · 1 personInsiders: 8 sales (~$2.6M)
  3. Mar 5, 2026Insider · 1 personInsiders: 13 sales (~$2.1M)
  4. Mar 11, 2026InsiderOfficer sold ~$803K of TMO shares in the open market
  5. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  6. Mar 27, 2026Federal contract · $4.5M obligatedDepartment of Commerce awarded Thermo Fisher Scientific: $4.49M obligated to date
  7. Mar 27, 2026CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  8. Apr 23, 2026Company filing · Form 8-K · ResultsReported its results
  9. Apr 27, 2026 · this disclosureInsiderOfficer sold ~$185K of TMO shares in the open market

What came next

  1. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  2. May 7, 2026CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
  3. Jun 4, 2026Federal contract · $1.6M obligatedDepartment of Defense awarded Thermo Fisher Scientific: $1.57M obligated to date
  4. Jun 9, 2026Federal contract · $1.5M obligatedDepartment of Agriculture awarded Thermo Fisher Scientific: $1.5M obligated to date
  5. Jul 10, 2026CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  6. Jul 21, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
  7. Jul 23, 2026Company filing · Form 8-K · ResultsReported its results
  8. Jul 24, 2026FDAFDA device clearance: Thermo Scientific Oxoid Cefepime/Zidebactam Disc (30/30 µg) FPZ60
  9. Jul 27, 2026InsiderOfficer sold ~$226K of TMO shares in the open market
  10. Aug 5, 2026Insider · 1 personInsiders: 19 sales (~$7.0M)
  11. Aug 6, 2026Insider · 2 peopleInsiders: 19 sales (~$12.0M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 93 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 143 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Gianluca Pettiti, President & COO

The full history of Gianluca Pettiti, President & COO is on the profile page.

How this filing works

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data